Persistence of increased left ventricular mass despite optimal blood pressure control in hypertension

Italian Heart Journal

Volumn 1, Issue 5, 2000, Pages 354-360

  Schillaci, G ^a   Verdecchia, P ^a   De Simone, G ^a   Sacchi, N ^a   Bruni, B ^a   Benemio, G ^a   Porcellati, C ^a  

^a Ospedale 'Beato G Villa'   (Italy)

Author keywords

Echocardiography; Hypertension, arterial; Hypertrophy; Treatment

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE MARKER; ESSENTIAL HYPERTENSION; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODYNAMICS; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SYSTOLIC BLOOD PRESSURE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CASE-CONTROL STUDIES; FEMALE; HUMAN; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SUPPORT, NON-U.S. GOV'T;

EID: 0033834387     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men
2. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension
3. Ambulatory blood pressure: An independent predictor of prognosis in essential hypertension
4. Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment
5. Prognostic significance of serial changes in left ventricular mass in essential hypertension
6. Blood pressure and the risks of cardiovascular disease
7. Antihypertensive drug therapy: Effects on stroke and coronary heart disease
8. Circadian blood pressure changes and left ventricular hypertrophy in essential hypertension
9. Predictors of diurnal blood pressure changes in 2042 subjects with essential hypertension
10. Recommendations regarding quantitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
11. Echocardiography in arterial hypertension: When, why and how?
12. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
13. Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and the impact of overweight
14. Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension
15. Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy
16. Problems in echocardiographic volume determinations: Echocardiographic-angiographic correlations in the presence or absence of asynergy
17. Estimation of left ventricular chamber and stroke volume by limited M-mode echocardiography: Validation by two-dimensional and Doppler echocardiography
18. Interaction between body size and cardiac workload: Influence on left ventricular mass during body growth and adulthood
19. Prevalence and determinants of left ventricular filling abnormalities in an unselected hypertensive population
20. Hypertensive cardiac hypertrophy: Pathophysiologic and clinical characteristics
21. Multiple standardized clinic blood pressures may predict left ventricular mass as well as ambulatory monitoring: A meta-analysis of comparative studies
22. Left ventricular mass and exercise responses predict future blood pressure: The Muscatine Study
23. Echocardiographic left ventricular mass and electrolyte intake predict arterial hypertension
24. Impact of left ventricular structure on the incidence of hypertension: The Framingham Heart Study
25. Left ventricular mass and subsequent blood pressure changes among middle-aged men in rural and urban Japanese populations
26. Plasma angiotensin II, predisposition to hypertension, left ventricular size in healthy young adults
27. Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system
28. Echocardiographic left ventricular hypertrophy as related to arterial pressure and plasma norepinephrine concentration in arterial hypertension: Reversal by atenolol treatment
29. Participation of endogenous catecholamines in the regulation of left ventricular mass in progeny of hypertensive parents
30. Independent genetic susceptibility to cardiac hypertrophy in inherited hypertension
31. Structural remodeling in hypertensive heart disease and the role of hormones
32. Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat
33. Effect of chronic high-and low-dose ACE inhibitor treatment on cardiac and vascular hypertrophy and vascular function in spontaneously hypertensive rats
34. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension
35. Time course of complete normalization of left ventricular hypertrophy during long-term antihypertensive therapy with angiotensin converting enzyme inhibitors
36. Cellular basis of ventricular remodeling in hypertensive cardiomyopathy
37. Inadequate, adequate and inappropriate left ventricular hypertrophy in arterial hypertension
38. Role of left ventricular hypertrophy in diastolic dysfunction in aged hypertensive patients
39. Left ventricular filling in arterial hypertension: Influence of obesity and hemodynamic and structural confounders
40. Profile of hypertension therapy in Italy: Results of the 'Study on antihypertensive treatment in general practice'
41. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996)
42. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the Treatment of Mild Hypertension Study (TOMHS)
43. Effect of single-drug therapy on reduction of left ventricular mass in mild to moderate hypertension: Comparison of six antihypertensive agents
44. Hydrochlorothiazide is superior to isradipine for reduction of left ventricular mass: Results of a multicenter trial. The Isradipine Study Group